AMNI — Amniotics AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK10.30m
- SEK2.09m
Annual cashflow statement for Amniotics AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Interim Report | Interim Report | ARS | Interim Report | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.7 | -31 | -53.6 | -46.7 | -29.1 |
| Depreciation | |||||
| Non-Cash Items | — | 0.061 | — | 5.85 | 0.099 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.84 | -32.4 | 35.8 | 6.04 | -3.82 |
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -8.87 | -61.8 | -15.6 | -33.5 | -29.1 |
| Capital Expenditures | — | — | -1.14 | — | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -6.4 | -5.47 | — | -1.36 | -2.67 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -6.4 | -5.47 | -1.14 | -1.36 | -2.67 |
| Financing Cash Flow Items | 20.2 | 1.45 | -0.116 | 14.5 | -3.92 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 20.2 | 61.7 | 60.2 | 14.5 | 30.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.95 | -5.52 | 43.5 | -20.4 | -0.892 |